A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer

NCT01874678 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small-cell Lung Cancer (NSCLC)

Interventions

DRUG: TS-1/Cisplatin

Sponsor

TTY Biopharm